Foguth Wealth Management LLC. Buys Shares of 1,205 Axon Enterprise, Inc $AXON

Posted by Brian Himes on Aug 2nd, 2026

Foguth Wealth Management LLC. purchased a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 1,205 shares of the biotechnology company’s stock, valued at approximately $541,000.

Several other large investors have also made changes to their positions in the company. Evergreen Capital Management LLC raised its position in Axon Enterprise by 3.8% during the second quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock valued at $342,000 after purchasing an additional 15 shares in the last quarter. Synergy Financial Group LTD boosted its holdings in shares of Axon Enterprise by 1.4% in the 3rd quarter. Synergy Financial Group LTD now owns 1,388 shares of the biotechnology company’s stock valued at $996,000 after purchasing an additional 19 shares in the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Axon Enterprise by 1.2% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,631 shares of the biotechnology company’s stock valued at $1,350,000 after purchasing an additional 19 shares during the last quarter. Certuity LLC increased its stake in shares of Axon Enterprise by 5.1% in the 4th quarter. Certuity LLC now owns 474 shares of the biotechnology company’s stock valued at $269,000 after purchasing an additional 23 shares during the last quarter. Finally, Pure Financial Advisors LLC raised its holdings in shares of Axon Enterprise by 6.7% during the 4th quarter. Pure Financial Advisors LLC now owns 364 shares of the biotechnology company’s stock worth $207,000 after buying an additional 23 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

AXON has been the subject of several recent analyst reports. Piper Sandler upped their price objective on Axon Enterprise from $674.00 to $724.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Weiss Ratings upgraded Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 8th. The Goldman Sachs Group set a $535.00 target price on Axon Enterprise in a research report on Thursday, May 7th. Barclays lowered their target price on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating for the company in a research note on Friday, May 8th. Finally, Morgan Stanley set a $600.00 target price on shares of Axon Enterprise in a report on Thursday, May 7th. Fifteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $725.25.

Check Out Our Latest Report on Axon Enterprise

Axon Enterprise Trading Up 0.5%

Shares of NASDAQ AXON opened at $527.76 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. Axon Enterprise, Inc has a 52-week low of $339.01 and a 52-week high of $885.91. The firm has a 50 day moving average price of $497.09 and a two-hundred day moving average price of $476.61. The stock has a market cap of $42.54 billion, a P/E ratio of 211.95, a price-to-earnings-growth ratio of 10.77 and a beta of 1.38.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.01. The firm had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.90 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The company’s revenue for the quarter was up 33.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.47 earnings per share. As a group, equities analysts forecast that Axon Enterprise, Inc will post 1.63 EPS for the current year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 20,000 shares of the company’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $500.00, for a total value of $10,000,000.00. Following the sale, the chief executive officer owned 3,060,997 shares in the company, valued at approximately $1,530,498,500. The trade was a 0.65% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 13,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $488.45, for a total value of $6,349,850.00. Following the transaction, the president owned 169,125 shares of the company’s stock, valued at $82,609,106.25. This trade represents a 7.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 58,989 shares of company stock worth $30,527,983 over the last 90 days. Company insiders own 4.20% of the company’s stock.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.